Medical Education Library

Managing Hypoglycemia in Primary Care

This supplement was sponsored by the Primary Care Education Consortium and the Primary Care Metabolic Group and was supported by Novo Nordisk, Inc. It has been edited and peer reviewed by The Journal of Family Practice.

 

Hypoglycemia is one of the most serious complications associated with glucose-lowering therapy and is a barrier to initiating, intensifying, and optimizing therapy, as well as long-term adherence. The risk and severity of hypoglycemia can be reduced through careful selection and use of glucose-lowering therapy based on patient characteristics and capabilities. Also of critical importance is to help patients improve self-management by providing support, education, and interventions in consideration of cultural beliefs, health literacy and numeracy, hypoglycemia awareness, and past experience with hypoglycemia.

Recommended Reading

Fight Obesity with Specific, Countable Goals
Type 2 Diabetes ICYMI
Radiation to Pancreas Linked with Diabetes in Childhood Cancer Survivors
Type 2 Diabetes ICYMI
Bariatric Surgery Prevents Type 2 Diabetes
Type 2 Diabetes ICYMI
Computer Algorithm Improved ICU Glucose Control
Type 2 Diabetes ICYMI
Medicare Okays Wound Plasma Gel for Clinical Trial Patients
Type 2 Diabetes ICYMI
Glycemic Variation Increased in Nondiabetic Obese People
Type 2 Diabetes ICYMI
GRACE: Insulin Glargine Fails to Halt Atherosclerosis Progression
Type 2 Diabetes ICYMI
Gastric Bypass Benefits Persist at 6 Years' Follow-Up
Type 2 Diabetes ICYMI
Hypoglycemia in ICU Patients Strongly Linked to Death
Type 2 Diabetes ICYMI
Severe Psoriasis Linked to Doubled Diabetes Risk
Type 2 Diabetes ICYMI